POLL: Which Skin Cancer Drug Recently Received a Complete Response Letter From the FDA?

Retrieved on: 2023-12-19 16:01:17

Tags for this article:

Click the tags to see associated articles and topics

POLL: Which Skin Cancer Drug Recently Received a Complete Response Letter From the FDA?. View article details on hiswai:

Excerpt

Moderna and Merck recently announced follow-up data from the phase 2b randomized KEYNOTE-942/mRNA-4157-P201 study, a clinical trial evaluating ...

Article found on: www.dermatologytimes.com